Cardiff Oncology to Present at Upcoming Investor Conferences in May GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on CRDF
    Thinking about buying stock in Recursion Pharmaceuticals, SoundHound AI, Cardiff Oncology, Mind Medicine, or Auddia?
    9:31a ET March 11 '24 PR Newswire

    InvestorsObserver issues critical PriceWatch Alerts for RXRX, SOUN, CRDF, MNMD, and AUUD.

    https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

    To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

    -- RXRX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=RXRX&prnumber=202403110

    -- SOUN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SOUN&prnumber=202403110

    -- CRDF: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CRDF&prnumber=202403110

    -- MNMD: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=MNMD&prnumber=202403110

    -- AUUD: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AUUD&prnumber=202403110

    (Note: You may have to copy this link into your browser then press the [ENTER] key.)

    InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

    InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

    https://c212.net/c/img/favicon.png?sn=CG57622&sd=2024-03-11

    View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-recursion-pharmaceuticals-soundhound-ai-cardiff-oncology-mind-medicine-or-auddia-302085256.html

    SOURCE InvestorsObserver

    https://rt.newswire.ca/rt.gif?NewsItemId=CG57622&Transmission_Id=202403110931PR_NEWS_USPR_____CG57622&DateId=20240311

    COMTEX_449080200/1005/2024-03-11T09:31:29

    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:16p ET May 9 '24 PR Newswire Europe
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:15p ET May 9 '24 PR Newswire
    Cardiff Oncology Reports First Quarter 2024 Results and Provides Busi...
    4:05p ET May 2 '24 GlobeNewswire
    Cardiff Oncology to Report First Quarter 2024 Results and Provide Bus...
    4:05p ET April 25 '24 GlobeNewswire
    Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeti...
    4:05p ET April 8 '24 GlobeNewswire
    Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Ther...
    9:31a ET March 26 '24 PR Newswire
    Thinking about buying stock in Mind Medicine, Ocean Biomedical, Arche...
    9:45a ET March 15 '24 PR Newswire
    Thinking about buying stock in SoundHound AI, Kinross Gold, Nu Holdin...
    9:31a ET March 14 '24 PR Newswire
    Thinking about buying stock in ShiftPixy, Minim, Cardiff Oncology, La...
    9:31a ET March 13 '24 PR Newswire
    Thinking about buying stock in Recursion Pharmaceuticals, SoundHound ...
    9:31a ET March 11 '24 PR Newswire

    Market data provided by News provided by